Your browser doesn't support javascript.
loading
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation.
Norman, Joshua S; Li, P Jonathan; Kotwani, Prashant; Shui, Amy M; Yao, Francis; Mehta, Neil.
Affiliation
  • Norman JS; University of California San Francisco School of Medicine, San Francisco, CA, USA; Department of Internal Medicine, Stanford, CA, USA.
  • Li PJ; University of California San Francisco School of Medicine, San Francisco, CA, USA.
  • Kotwani P; Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Shui AM; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
  • Yao F; Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Mehta N; Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA. Electronic address: neil.mehta@ucsf.edu.
J Hepatol ; 79(6): 1469-1477, 2023 12.
Article in En | MEDLINE | ID: mdl-37683735

Full text: 1 Database: MEDLINE Main subject: Liver Transplantation / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Liver Transplantation / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2023 Type: Article Affiliation country: United States